Advanced search
Publication Cover
Drug Delivery Volume 24, 2017 - Issue 1
Submit an article Journal homepage
3,396
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Design of a novel curcumin-soybean phosphatidylcholine complex-based targeted drug delivery systems

Jiajiang Xie1 Xiamen Xianyue Hospital, Xiamen, China, ;2 Department of Biomaterials, College of Materials, Xiamen University, Xiamen, China, and
,
Yanxiu Li2 Department of Biomaterials, College of Materials, Xiamen University, Xiamen, China, and
,
Liang Song2 Department of Biomaterials, College of Materials, Xiamen University, Xiamen, China, and
,
Zhou Pan2 Department of Biomaterials, College of Materials, Xiamen University, Xiamen, China, and
,
Shefang Ye2 Department of Biomaterials, College of Materials, Xiamen University, Xiamen, China, and
&
Zhenqing Hou2 Department of Biomaterials, College of Materials, Xiamen University, Xiamen, China, and ;3 Department of Physics, Changji University, Changji, ChinaCorrespondence[email protected]
Pages 707-719 | Received 13 Dec 2016, Accepted 05 Mar 2017, Published online: 24 Apr 2017

References

  • Acharya G, Park K. (2006). Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 58:387–401
  • Aggarwal BB, Kumar A, Bharti AC. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363–98
  • Aggarwal BB, Sundaram C, Malani N, et al. (2007). Curcumin: the Indian solid gold. Adv Exp Med Biol 595:1–75
  • Ahmad H, Arya A, Agrawal S, et al. (2016). Phospholipid complexation of NMITLI118RT+: way to a prudent therapeutic approach for beneficial outcomes in ischemic stroke in rats. Drug Deliv 23:3606–18
  • Anirudhan TS, Binusreejayan. (2016). Dextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cells. Int J Biol Macromol 88:222–35
  • Anitha A, Maya S, Deepa N, et al. (2012). Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery. J Biomater Sci Polym Ed 23:1381–400
  • Balogun E, Hoque M, Gong P, et al. (2003). Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371:887–95
  • Blagden N, de Matas M, Gavan PT, et al. (2007). Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 59:617–30
  • Byrne JD, Betancourt T, Brannon-Peppas L. (2008). Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60:1615–26
  • Chabner BA, Roberts TG. Jr. (2005). Timeline: chemotherapy and the war on cancer. Nat Rev Cancer 5:65–72
  • Cheng CJ, Tietjen GT, Saucier-Sawyer JK, et al. (2015). A holistic approach to targeting disease with polymeric nanoparticles. Nat Rev Drug Discov 14:239–47
  • Chou TC. (2006). Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621–81
  • Cui F, Shi K, Zhang L, et al. (2006). Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release 114:242–50
  • Danhier F, Feron O, Preat V. (2010). To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–46
  • Dhule SS, Penfornis P, Frazier T, et al. (2012). Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine 8:440–51
  • Duvoix A, Blasius R, Delhalle S, et al. (2005). Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223:181–90
  • Hou Z, Li Y, Huang Y, et al. (2013). Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm 10:90–101
  • Khan J, Alexander A, Ajazuddin, et al. (2013). Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. J Control Release 168:50–60
  • Khatik R, Dwivedi P, Shukla A, et al. (2016). Development, characterization and toxicological evaluations of phospholipids complexes of curcumin for effective drug delivery in cancer chemotherapy. Drug Deliv 23:1057–68
  • Kidd PM. (2009). Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 14:226–46
  • Kuo ML, Huang TS, Lin JK. (1996). Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1317:95–100
  • Li Y, Lin J, Liu G, et al. (2016). Self-assembly of multifunctional integrated nanoparticles loaded with a methotrexate-phospholipid complex: combining simplicity and efficacy in both targeting and anticancer effects. RSC Adv 6:86717–27
  • Li Y, Lin J, Wu H, et al. (2015a). Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect. Mol Pharm 12:769–82
  • Li Y, Lin J, Yang X, et al. (2015b). Self-assembled nanoparticles based on amphiphilic anticancer drug-phospholipid complex for targeted drug delivery and intracellular dual-controlled release. ACS Appl Mater Interfaces 7:17573–81
  • Li Y, Wu H, Yang X, et al. (2014). Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release. Mol Pharm 11:2915–27
  • Liu H, Lu H, Liao L, et al. (2015). Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies. Drug Deliv 22:701–9
  • Liu J, Gong T, Wang C, et al. (2007). Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm 340:153–62
  • Ma Y, Li H, Guan S. (2013). Characteristics and evaluation of an injectable clarithromycin lipid-based complex in vitro and in vivo. Drug Deliv 20:349–55
  • Maiti K, Mukherjee K, Gantait A, et al. (2007). Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330:155–63
  • Peer D, Karp JM, Hong S, et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–60
  • Reuter S, Eifes S, Dicato M, et al. (2008). Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76:1340–51
  • Rizvi S, Gores GJ. (2013). Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145:1215–29
  • Rose PG, Bundy BN, Watkins EB, et al. (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–53
  • Siegel RL, Miller KD, Jemal A. (2015). Cancer statistics, 2015. CA Cancer J Clin 65:5–29
  • Stella VJ, Nti-Addae KW. (2007). Prodrug strategies to overcome poor water solubility. Adv Drug Deliv Rev 59:677–94
  • Torchilin V. (2011). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–5
  • Zhang Z, Chen Y, Deng J, et al. (2014). Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO2: preparation, characterization and in vivo studies. Int J Pharm 465:306–16

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.